Multiple Burrhole Therapy With Erythropoietin for Unstable Moyamoya

Completed

Phase 1/2 Results N/A

Summary of Purpose

In this study, the investigators aim to evaluate the indirect revascularization outcomes of a new combination therapy of multiple burrhole procedure with promotion of arteriogenesis by intravenous (IV) erythropoietin (EPO) pretreatment on Moyamoya patients with acute neurological presentation, and outline the clinical and vascular factors associated with revascularization through the burrholes.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 19 June 2017.

1 May 2010 18 May 2017 30 Sep 2016 30 Sep 2016 1 Jun 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available

Contacts

Not available